Currently, most BETi target all the members of BET subfamily, including BRD2, BRD3, BRD4 and BRDT.23,30,49,50 These proteins might have both distinct and overlapping functions, which requires deeper understanding of the mechanism of action, and oncogenic driver activity, of these proteins in different cancers. Here, BRD4 is linked to cancer.